Matches in Nanopublications for { ?s ?p "Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97" ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- _3 value "Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97" provenance.
- _3 value "Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97" provenance.
- _3 value "Treatment of VSMCs with AG-II was observed to induce premature cellular senescence (overexpression of p53/p21) and increase the production of proinflammatory cytokines through nuclear factor-B activation; both effects were neutralized by blocking the p21 pathway.97 The same effects of AG-II were also observed in vivo in a mouse model of atherosclerosis.97" provenance.